Clinical Trials Directory

Trials / Sponsors / Sichuan Huiyu Pharmaceutical Co., Ltd

Sichuan Huiyu Pharmaceutical Co., Ltd

Industry · 13 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors
Advanced Solid Tumor
Phase 1 / Phase 22025-07-22
RecruitingA Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors
Solid Tumor
Phase 1 / Phase 22025-07-21
Active Not RecruitingHuman Bioequivalence Study of Liposomal Amphotericin B for Injection
Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis
N/A2025-05-25
CompletedHuman Bioequivalence Study of Amphotericin B Liposome for Injection
Invasive Fungal Infections, Neutropenic Fever, Visceral Leishmaniasis
N/A2025-05-13
CompletedBioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants
Healthy Adult
Phase 12025-04-07
RecruitingBioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
Breast Cancer
N/A2025-03-12
RecruitingA Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation
Moderate or Severe Submental Fullness
Phase 12024-12-26
RecruitingA Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine
Solid Tumor
Phase 1 / Phase 22024-11-27
CompletedBioequivalence Study of Iron Sucrose Injection in Healthy Participants
Bioequivalency, Safety Issues
Phase 12024-11-22
RecruitingPhase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
Safety, Tolerability, Efficacy
Phase 1 / Phase 22024-10-24
CompletedBioequivalence Study of Iron Sucrose Injection in Healthy Subjects
Bioequivalency, Safety Issues
Phase 12024-06-25
RecruitingPhase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation
Safety, Tolerability, Efficacy
Phase 1 / Phase 22024-02-04
CompletedBioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
Iron Deficiency, Anaemia
Phase 12023-10-09